vs
Side-by-side financial comparison of Syndax Pharmaceuticals Inc (SNDX) and UNITY BANCORP INC (UNTY). Click either name above to swap in a different company.
Syndax Pharmaceuticals Inc is the larger business by last-quarter revenue ($68.5M vs $35.3M, roughly 1.9× UNITY BANCORP INC). UNITY BANCORP INC runs the higher net margin — 43.9% vs -99.3%, a 143.2% gap on every dollar of revenue. On growth, Syndax Pharmaceuticals Inc posted the faster year-over-year revenue change (791.7% vs 24.2%).
Syndax Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing innovative oncology therapies for patients with hard-to-treat cancers. Its pipeline includes targeted and immunotherapy candidates addressing unmet medical needs, primarily serving global oncology healthcare stakeholders and patient populations.
Unity Bancorp Inc is a New Jersey-headquartered financial holding company operating Unity Bank. It offers a full range of commercial and retail banking services including business loans, deposit products, mortgage services, and personal banking solutions, primarily serving small and medium-sized enterprises and individual consumers across local communities in New Jersey and eastern Pennsylvania.
SNDX vs UNTY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $68.5M | $35.3M |
| Net Profit | $-68.0M | $15.5M |
| Gross Margin | — | — |
| Operating Margin | -91.3% | 55.8% |
| Net Margin | -99.3% | 43.9% |
| Revenue YoY | 791.7% | 24.2% |
| Net Profit YoY | 27.8% | 34.5% |
| EPS (diluted) | $-0.78 | $1.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $68.5M | $35.3M | ||
| Q3 25 | $45.9M | $32.8M | ||
| Q2 25 | $38.0M | $34.4M | ||
| Q1 25 | $20.0M | $29.4M | ||
| Q4 24 | — | $28.4M | ||
| Q3 24 | $12.5M | $27.7M | ||
| Q2 24 | — | $25.5M | ||
| Q1 24 | $0 | $25.6M |
| Q4 25 | $-68.0M | $15.5M | ||
| Q3 25 | $-60.7M | $14.4M | ||
| Q2 25 | $-71.8M | $16.5M | ||
| Q1 25 | $-84.8M | $11.6M | ||
| Q4 24 | — | $11.5M | ||
| Q3 24 | $-84.1M | $10.9M | ||
| Q2 24 | — | $9.5M | ||
| Q1 24 | $-72.4M | $9.6M |
| Q4 25 | -91.3% | 55.8% | ||
| Q3 25 | -125.2% | 57.5% | ||
| Q2 25 | -182.7% | 62.6% | ||
| Q1 25 | -417.9% | 52.6% | ||
| Q4 24 | — | 51.0% | ||
| Q3 24 | -716.6% | 52.7% | ||
| Q2 24 | — | 49.3% | ||
| Q1 24 | — | 50.0% |
| Q4 25 | -99.3% | 43.9% | ||
| Q3 25 | -132.4% | 43.8% | ||
| Q2 25 | -189.3% | 48.0% | ||
| Q1 25 | -423.3% | 39.5% | ||
| Q4 24 | — | 40.5% | ||
| Q3 24 | -673.0% | 39.4% | ||
| Q2 24 | — | 37.1% | ||
| Q1 24 | — | 37.5% |
| Q4 25 | $-0.78 | $1.52 | ||
| Q3 25 | $-0.70 | $1.41 | ||
| Q2 25 | $-0.83 | $1.61 | ||
| Q1 25 | $-0.98 | $1.13 | ||
| Q4 24 | — | $1.13 | ||
| Q3 24 | $-0.98 | $1.07 | ||
| Q2 24 | — | $0.92 | ||
| Q1 24 | $-0.85 | $0.94 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $394.1M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $64.6M | $345.6M |
| Total Assets | $529.7M | $3.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $394.1M | — | ||
| Q3 25 | $436.0M | — | ||
| Q2 25 | $455.2M | — | ||
| Q1 25 | $512.2M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $389.6M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $434.6M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $230.8M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $64.6M | $345.6M | ||
| Q3 25 | $115.4M | $334.0M | ||
| Q2 25 | $157.4M | $319.8M | ||
| Q1 25 | $215.1M | $306.1M | ||
| Q4 24 | — | $295.6M | ||
| Q3 24 | $366.4M | $284.3M | ||
| Q2 24 | — | $273.4M | ||
| Q1 24 | $491.9M | $266.8M |
| Q4 25 | $529.7M | $3.0B | ||
| Q3 25 | $551.8M | $2.9B | ||
| Q2 25 | $596.1M | $2.9B | ||
| Q1 25 | $640.7M | $2.8B | ||
| Q4 24 | — | $2.7B | ||
| Q3 24 | $425.8M | $2.6B | ||
| Q2 24 | — | $2.6B | ||
| Q1 24 | $543.0M | $2.6B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-69.5M | $44.9M |
| Free Cash FlowOCF − Capex | — | $44.3M |
| FCF MarginFCF / Revenue | — | 125.7% |
| Capex IntensityCapex / Revenue | — | 1.6% |
| Cash ConversionOCF / Net Profit | — | 2.90× |
| TTM Free Cash FlowTrailing 4 quarters | — | $81.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-69.5M | $44.9M | ||
| Q3 25 | $-70.5M | $45.5M | ||
| Q2 25 | $-87.8M | $-25.3M | ||
| Q1 25 | $-95.2M | $17.9M | ||
| Q4 24 | — | $48.0M | ||
| Q3 24 | $-62.3M | $17.7M | ||
| Q2 24 | — | $-8.4M | ||
| Q1 24 | $-83.5M | $15.8M |
| Q4 25 | — | $44.3M | ||
| Q3 25 | — | $45.3M | ||
| Q2 25 | — | $-25.5M | ||
| Q1 25 | — | $17.6M | ||
| Q4 24 | — | $47.3M | ||
| Q3 24 | — | $17.5M | ||
| Q2 24 | — | $-8.6M | ||
| Q1 24 | — | $15.7M |
| Q4 25 | — | 125.7% | ||
| Q3 25 | — | 138.1% | ||
| Q2 25 | — | -74.2% | ||
| Q1 25 | — | 59.9% | ||
| Q4 24 | — | 166.5% | ||
| Q3 24 | — | 63.3% | ||
| Q2 24 | — | -33.7% | ||
| Q1 24 | — | 61.4% |
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 0.3% |
| Q4 25 | — | 2.90× | ||
| Q3 25 | — | 3.16× | ||
| Q2 25 | — | -1.54× | ||
| Q1 25 | — | 1.54× | ||
| Q4 24 | — | 4.17× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | — | -0.89× | ||
| Q1 24 | — | 1.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
